Mechanistically, dexamethasone (DEX) reduces GLI1 transcriptional activity (as demonstrated by PTCH1 and HHIP downregulation) while initially upregulating its expression levels in HSB2 and DND-41 T-ALL cells. This evidence concerns the gene PTCH1 and acute lymphoblastic leukemia.